Publications by authors named "Robby M Goh"
Article Synopsis
- The study aims to evaluate and compare the efficacy and side effects of weekly versus tri-weekly administration of paclitaxel, alongside carboplatin, as the first-line treatment for newly diagnosed epithelial ovarian cancer.
- The researchers systematically reviewed numerous databases for randomized controlled trials, measuring outcomes like progression-free survival, overall survival, and adverse effects, applying standardized methodology for data collection and analysis.
Purpose: Induction cisplatin and gemcitabine chemotherapy is a standard treatment for locally advanced nasopharyngeal carcinoma (NPC). Inhibition of VEGF axis has been shown to promote maturation of microvasculature and improve perfusion. We conducted a four-arm study to assess the effect of two doses of either sunitinib or bevacizumab with chemotherapy in NPC.
View Article and Find Full Text PDFc-MET receptors are activated in cancers through genomic events like tyrosine kinase domain mutations, juxtamembrane splicing mutation and amplified copy numbers, which can be inhibited by c-MET small molecule inhibitors. Here, we discover that the most common polymorphism known to affect MET gene (N375S), involving the semaphorin domain, confers exquisite binding affinity for HER2 and enables MET to interact with HER2 in a ligand-independent fashion. The resultant MET/HER2 dimer transduces potent proliferative, pro-invasive and pro-metastatic cues through the HER2 signaling axis to drive aggressive squamous cell carcinomas of the head and neck (HNSCC) and lung (LUSC), and is associated with poor prognosis.
View Article and Find Full Text PDF